Iovance Biotherapeutics (0JDK) Revenue

5 Followers

Iovance Biotherapeutics Revenue

Iovance Biotherapeutics had a revenue of 99.31M in the quarter ending Jun 30, 2026, with 39.04%. This bring the company's revenue in the last twelve months to 324.97M, Decreased 13.78%. In the fiscal year ending Dec 31, 2025, Iovance Biotherapeutics had annual revenue of 263.50M with 60.60% growth.

Revenue (ttm)

324.97M

Revenue Growth

34.52%

P/S Ratio

18.57

Revenue/Employee

$270,258

Employees

975

Market Cap

$4.89B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	263.50M	99.43M	+60.60%
Dec 31, 2024	164.07M	162.88M	+13,698.99%
Dec 31, 2023	1.19M	―	+∞%
Dec 31, 2022	―	―	―
Dec 31, 2021	―	―	―
Dec 31, 2020	―	―	―
Dec 31, 2019	―	―	―
Dec 31, 2018	―	―	―
Dec 31, 2017	―	―	―